Neoplasia syndromes

David M. Gamm, Amol D. Kulkarni, Daniel Albert

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Tradition holds that the varied disorders collectively referred to as the phakomatoses be discussed together. However, from a genetic, developmental, and clinical standpoint, the designation has limited usefulness, as can be deduced from efforts to define the term (130,131,145). The phakomatoses comprise a heterogenous group of diseases that feature widespread, tumor likemalformations (130,242) consisting of tissue components normally found at the involved site (hamartomas) (5,251). The hamartomas are usually congenital and tend to involve the central nervous system (CNS), retina, and skin, and thus the conditions are also referred to as the “neurocutaneous syndromes” (2,254). The label “phakomatoses,” derived from the Greek root for “mother spot” or birthmark, was introduced in 1932 by van der Hoeve (130), who substituted the term “phakoma” in preference to the designation “nevus,” which pathologists had previously applied to these conditions (234,235). Originally, three entities were included under the classification of phakomatosis: angiomatosis retinae [von Hippel-Lindau disease (VHLD)]; neurofibromatosis (NF); and tuberous sclerosis (now called tuberous sclerosis complex) (TSC). It is noteworthy that these “original three” phakomatoses have subsequently been shown to develop from mutations in genes involved in the control of cell replication and the suppression of tumor formation (130,145). Thus, scientific discovery established a link between these entities that supports the grouping of at least some of the phakomatoses. However, it is important to realize that the genes involved in VHLD, NF, and TSC differ, and their clinical manifestations are dissimilar (130).

Original languageEnglish (US)
Title of host publicationGarner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition
PublisherCRC Press
Pages1185-1208
Number of pages24
ISBN (Electronic)9781420093919
ISBN (Print)142007976X, 9781420079760
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Neurocutaneous Syndromes
von Hippel-Lindau Disease
Tuberous Sclerosis
Neoplasms
Neurofibromatoses
Hamartoma
Nevus
Genes
Retina
Central Nervous System
Mothers
Skin
Mutation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gamm, D. M., Kulkarni, A. D., & Albert, D. (2007). Neoplasia syndromes. In Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition (pp. 1185-1208). CRC Press.

Neoplasia syndromes. / Gamm, David M.; Kulkarni, Amol D.; Albert, Daniel.

Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press, 2007. p. 1185-1208.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gamm, DM, Kulkarni, AD & Albert, D 2007, Neoplasia syndromes. in Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press, pp. 1185-1208.
Gamm DM, Kulkarni AD, Albert D. Neoplasia syndromes. In Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press. 2007. p. 1185-1208
Gamm, David M. ; Kulkarni, Amol D. ; Albert, Daniel. / Neoplasia syndromes. Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition. CRC Press, 2007. pp. 1185-1208
@inbook{f332bd086d7242fba4ad21210f2d0089,
title = "Neoplasia syndromes",
abstract = "Tradition holds that the varied disorders collectively referred to as the phakomatoses be discussed together. However, from a genetic, developmental, and clinical standpoint, the designation has limited usefulness, as can be deduced from efforts to define the term (130,131,145). The phakomatoses comprise a heterogenous group of diseases that feature widespread, tumor likemalformations (130,242) consisting of tissue components normally found at the involved site (hamartomas) (5,251). The hamartomas are usually congenital and tend to involve the central nervous system (CNS), retina, and skin, and thus the conditions are also referred to as the “neurocutaneous syndromes” (2,254). The label “phakomatoses,” derived from the Greek root for “mother spot” or birthmark, was introduced in 1932 by van der Hoeve (130), who substituted the term “phakoma” in preference to the designation “nevus,” which pathologists had previously applied to these conditions (234,235). Originally, three entities were included under the classification of phakomatosis: angiomatosis retinae [von Hippel-Lindau disease (VHLD)]; neurofibromatosis (NF); and tuberous sclerosis (now called tuberous sclerosis complex) (TSC). It is noteworthy that these “original three” phakomatoses have subsequently been shown to develop from mutations in genes involved in the control of cell replication and the suppression of tumor formation (130,145). Thus, scientific discovery established a link between these entities that supports the grouping of at least some of the phakomatoses. However, it is important to realize that the genes involved in VHLD, NF, and TSC differ, and their clinical manifestations are dissimilar (130).",
author = "Gamm, {David M.} and Kulkarni, {Amol D.} and Daniel Albert",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "142007976X",
pages = "1185--1208",
booktitle = "Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition",
publisher = "CRC Press",

}

TY - CHAP

T1 - Neoplasia syndromes

AU - Gamm, David M.

AU - Kulkarni, Amol D.

AU - Albert, Daniel

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Tradition holds that the varied disorders collectively referred to as the phakomatoses be discussed together. However, from a genetic, developmental, and clinical standpoint, the designation has limited usefulness, as can be deduced from efforts to define the term (130,131,145). The phakomatoses comprise a heterogenous group of diseases that feature widespread, tumor likemalformations (130,242) consisting of tissue components normally found at the involved site (hamartomas) (5,251). The hamartomas are usually congenital and tend to involve the central nervous system (CNS), retina, and skin, and thus the conditions are also referred to as the “neurocutaneous syndromes” (2,254). The label “phakomatoses,” derived from the Greek root for “mother spot” or birthmark, was introduced in 1932 by van der Hoeve (130), who substituted the term “phakoma” in preference to the designation “nevus,” which pathologists had previously applied to these conditions (234,235). Originally, three entities were included under the classification of phakomatosis: angiomatosis retinae [von Hippel-Lindau disease (VHLD)]; neurofibromatosis (NF); and tuberous sclerosis (now called tuberous sclerosis complex) (TSC). It is noteworthy that these “original three” phakomatoses have subsequently been shown to develop from mutations in genes involved in the control of cell replication and the suppression of tumor formation (130,145). Thus, scientific discovery established a link between these entities that supports the grouping of at least some of the phakomatoses. However, it is important to realize that the genes involved in VHLD, NF, and TSC differ, and their clinical manifestations are dissimilar (130).

AB - Tradition holds that the varied disorders collectively referred to as the phakomatoses be discussed together. However, from a genetic, developmental, and clinical standpoint, the designation has limited usefulness, as can be deduced from efforts to define the term (130,131,145). The phakomatoses comprise a heterogenous group of diseases that feature widespread, tumor likemalformations (130,242) consisting of tissue components normally found at the involved site (hamartomas) (5,251). The hamartomas are usually congenital and tend to involve the central nervous system (CNS), retina, and skin, and thus the conditions are also referred to as the “neurocutaneous syndromes” (2,254). The label “phakomatoses,” derived from the Greek root for “mother spot” or birthmark, was introduced in 1932 by van der Hoeve (130), who substituted the term “phakoma” in preference to the designation “nevus,” which pathologists had previously applied to these conditions (234,235). Originally, three entities were included under the classification of phakomatosis: angiomatosis retinae [von Hippel-Lindau disease (VHLD)]; neurofibromatosis (NF); and tuberous sclerosis (now called tuberous sclerosis complex) (TSC). It is noteworthy that these “original three” phakomatoses have subsequently been shown to develop from mutations in genes involved in the control of cell replication and the suppression of tumor formation (130,145). Thus, scientific discovery established a link between these entities that supports the grouping of at least some of the phakomatoses. However, it is important to realize that the genes involved in VHLD, NF, and TSC differ, and their clinical manifestations are dissimilar (130).

UR - http://www.scopus.com/inward/record.url?scp=85057916477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057916477&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85057916477

SN - 142007976X

SN - 9781420079760

SP - 1185

EP - 1208

BT - Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition

PB - CRC Press

ER -